We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Vaxneuvance
Australian Public Assessment Report
Device/Product Name
Vaxneuvance
Active ingredients
Pneumococcal 15-valent conjugate vaccine (CRM197 protein), adsorbed
AusPAR Date
Published
Submission Number
PM-2020-06364-1-2
Submission Type
New biological entity
Decision
Approved